Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Oncotarget|September 28, 2014
Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic diseaseHeidi N Hilton, Tram B Doan, J Dinny Graham, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Nuclear hormone receptorsStephen P H Alexander, John A Cidlowski, Alasdair J Gibb, et al.
European Journal of Preventive Cardiology|March 20, 2021
Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH studyGian Paolo Rossi, Giacomo Rossitto, Laurence Amar, et al.
Hypertension (Dallas, Tex. : 1979)|March 25, 2024
Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor BlockadeGiovanni Pintus, Teresa Maria Seccia, Laurence Amar, et al.
Hypertension (Dallas, Tex. : 1979)|December 8, 2021
Feasibility of Imaging-Guided Adrenalectomy in Young Patients With Primary AldosteronismGian Paolo Rossi, Filippo Crimì, Giacomo Rossitto, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2021
Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large, Multiethnic International StudyGian Paolo Rossi, Filippo Crimì, Giacomo Rossitto, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2023
Unilaterally Selective Adrenal Vein Sampling for Identification of Surgically Curable Primary AldosteronismGian Paolo Rossi, Domenico Bagordo, Laurence Amar, et al.
Hypertension (Dallas, Tex. : 1979)|September 4, 2019
Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein SamplingGian Paolo Rossi, Giacomo Rossitto, Laurence Amar, et al.
Hypertension (Dallas, Tex. : 1979)|July 22, 2026
Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 MonthsJun Yang, Jessica Goi, Jacopo Burrello, et al.
The Lancet. Diabetes & Endocrinology|January 17, 2025
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohortJun Yang, Jacopo Burrello, Jessica Goi, et al.
Pageof 20